Medical News / Coverage ASRS 2019: FAi Insert for Treatment of Non-Infectious Posterior Segment Uveitis

New data on the 36-month outcomes of injectable fluocinolone acetonide intravitreal insert (FAi) on recurrences of non-infectious posterior segment uveitis was presented on Tuesday afternoon at the 2019 American Society of Retina Specialists Annual Meeting in Chicago, IL. Quan Dong Nguyen, MD, MSc, professor of ophthalmology at Stanford University Medical Center, presented the results of the study, which found that treatment with a single intravitreal injection of the FAi provided anti-inflammatory treatment for 3 years in patients with non-infectious uveitis affecting the posterior segment of the eye. Source: MDmag By reading more or clicking on the link below, you are leaving this site and going to another site run by another organization

read more

MORE MEDICAL NEWS
Developing a greater understanding of associations and risk factors, even among common conditions, can pay great ... read more
A new era in the treatment of age-related macular degeneration could be on the horizon, as ... read more
Mixed in with the massive screens and eye-catching displays of the various companies use to represent ... read more
A new study examining the impact of guideline changes in Europe is suggesting use of topical ... read more